Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004664755 | SCV005150727 | uncertain significance | not specified | 2024-05-24 | criteria provided, single submitter | clinical testing | The c.323C>T (p.S108L) alteration is located in exon 5 (coding exon 2) of the COLCA2 gene. This alteration results from a C to T substitution at nucleotide position 323, causing the serine (S) at amino acid position 108 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |